1. Home
  2. PKOH vs DCTH Comparison

PKOH vs DCTH Comparison

Compare PKOH & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Park-Ohio Holdings Corp.

PKOH

Park-Ohio Holdings Corp.

HOLD

Current Price

$24.28

Market Cap

299.5M

Sector

Industrials

ML Signal

HOLD

Logo Delcath Systems Inc.

DCTH

Delcath Systems Inc.

HOLD

Current Price

$9.48

Market Cap

350.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PKOH
DCTH
Founded
1907
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
299.5M
350.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PKOH
DCTH
Price
$24.28
$9.48
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$23.00
AVG Volume (30 Days)
20.8K
481.6K
Earning Date
03-04-2026
03-05-2026
Dividend Yield
2.06%
N/A
EPS Growth
30.26
N/A
EPS
1.68
0.03
Revenue
$1,592,500,000.00
$79,603,000.00
Revenue This Year
N/A
$132.21
Revenue Next Year
$3.72
$33.88
P/E Ratio
$14.43
$288.94
Revenue Growth
N/A
251.54
52 Week Low
$15.52
$8.12
52 Week High
$26.31
$18.23

Technical Indicators

Market Signals
Indicator
PKOH
DCTH
Relative Strength Index (RSI) 65.99 38.17
Support Level $21.17 $9.74
Resistance Level $24.00 $11.15
Average True Range (ATR) 0.90 0.42
MACD 0.14 -0.10
Stochastic Oscillator 88.27 1.52

Price Performance

Historical Comparison
PKOH
DCTH

About PKOH Park-Ohio Holdings Corp.

Park-Ohio Holdings Corp is a company, engaged in industrial supply chain logistics and diversified manufacturing business. It operates in three business segments namely Supply Technologies, Assembly Components and Engineered Products. Geographically, the business of the group is amplifying across the region of the United States, Asia, Europe, Canada, Mexico and others. The company derives key revenue from the Supply Technologies segment which includes proactive solutions approach that manages the efficiencies of every aspect of supplying production parts and materials to customers' manufacturing floor, from strategic planning to program implementation.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: